Fund Holdings — M28 Capital Management LP

Total Portfolio Value
$47.16M
Total Bought
$0
Total Sold
$0
Net Transaction
$0
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
TG THERAPEUTICS INC(TGTX)88,35488,35402,9354,85410.29%+1,919
ARROWHEAD PHARMACEUTICALS IN(ARWR)36,85136,85102,3113,0046.37%+693
FRACTYL HEALTH INC(GUTS)1,856,1171,856,11708501,4743.13%+625
SILENCE THERAPEUTICS PLC(SLN)101,203101,20305331,1112.36%+578
PROQR THRAPEUTICS N V
SHS EURO
599,793599,79309721,1162.37%+144
CURIS INC(CRIS)284,889284,88901561490.32%-7
ROCKET PHARMACEUTICALS INC(RCKT)210,871210,87107557211.53%-34
INVIVYD INC(IVVD)9,248,2509,248,250012,0238,06817.11%-3,955
WAVE LIFE SCIENCES LTD(WVE)4,588,2844,588,284033,26526,65856.53%-6,607
Page 1 of 1
M28 Capital Management LP — 13F Holdings — Q2 2026 | TickerTrail